Lumbar spine bone mineral density response rates in a study of recombinant human parathyroid hormone (1-34) compared to alendronate sodium in postmenopausal women with osteoporosis.

被引：0
|
作者：
Kulkarni, PM
Gaich, GA
Scheele, WH
机构：
来源：
ARTHRITIS AND RHEUMATISM | 2001年 / 44卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1960
引用
收藏
页码：S379 / S379
页数：1
相关论文
共 50 条
  • [1] Changes in bone mineral density 18 months after cessation of recombinant human parathyroid hormone (1-34) or alendronate treatment in postmenopausal women with osteoporosis.
    Dore, RK
    Hodsman, AB
    Scheele, WH
    Body, JL
    Miller, PD
    Clancy, AD
    Myers, SL
    Gaich, GA
    [J]. ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S254 - S254
  • [2] Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.
    Neer, RM
    Arnaud, CD
    Zanchetta, JR
    Prince, R
    Gaich, GA
    Reginster, JY
    Hodsman, AB
    Eriksen, EF
    Ish-Shalom, S
    Genant, HK
    Wang, OH
    Mitlak, BH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (19): : 1434 - 1441
  • [3] Effects of LY333334 [recombinant human parathyroid hormone (1-34)] and alendronate sodium on markers of bone metabolism in postmenopausal women with osteoporosis.
    Body, JJ
    Gaich, GA
    Scheele, WH
    Kulkarni, PM
    Hodsman, AB
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S530 - S530
  • [4] Recombinant human parathyroid hormone (1-34) increases bone mineral density in men with both idiopathic and hypogonadal osteoporosis.
    Orwoll, ES
    Scheele, WH
    Clancy, AD
    Adami, S
    Syversen, U
    Kaufman, JM
    Diez-Perez, A
    [J]. ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S379 - S379
  • [5] A randomized controlled clinical trial to compare the efficacy of LY333334 [recombinant human parathyroid hormone (1-34)] and alendronate sodium in postmenopausal women with osteoporosis.
    Body, JJ
    Gaich, GA
    Scheele, WH
    Miller, PD
    Kulkarni, PM
    Hodsman, AB
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S179 - S179
  • [6] Men and postmenopausal women with osteoporosis have similar lumbar spine bone mineral density responses to recombinant human parathyroid hormone (1-34) despite pharmacokinetic and biochemical marker differences.
    Satterwhite, J
    Melnick, K
    O'Brien, L
    Myers, SL
    Heathman, M
    [J]. ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S255 - S255
  • [7] Effects of teriparatide [recombinant human parathyroid hormone (1-34)] on cortical bone in postmenopausal women with osteoporosis
    Zanchetta, JR
    Bogado, CE
    Ferretti, JL
    Wang, O
    Wilson, MG
    Sato, M
    Gaich, GA
    Dalsky, GP
    Myers, SL
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 (03) : 539 - 543
  • [8] Effect of recombinant human parathyroid hormone (1-34) on heart in postmenopausal women with osteoporosis
    Sugimoto, T.
    Kawaguchi, D.
    Horiguchi, M.
    Takamura, T.
    Izumi, D.
    Seko, T.
    Kasai, A.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 : 92 - 92
  • [9] Alendronate (ALN) exposure-response modeling of bone turnover biomarkers and lumbar spine bone mineral density (BMD) in postmenopausal women with osteoporosis.
    Liu, Q.
    Jin, B.
    Wang, X.
    Stoch, A.
    Verbruggen, N.
    He, W.
    Ince, A.
    Czachur, M.
    McCaffrey, L.
    Miller, D.
    Panebianco, D.
    Denker, A.
    Woolf, E.
    Santora, A.
    Stone, J.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 : S70 - S70
  • [10] Teriparatide (recombinant human parathyroid hormone 1-34) in postmenopausal women with osteoporosis: systematic review
    Moca Trevisani, Virginia Fernandes
    Riera, Rachel
    Imoto, Aline Mizusaki
    Saconato, Humberto
    Atallah, Alvaro Nagib
    [J]. SAO PAULO MEDICAL JOURNAL, 2008, 126 (05): : 279 - 284
12345